BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 18082413)

  • 1. The antiphospholipid syndrome and heart valve surgery.
    Gorki H; Malinovski V; Stanbridge RD
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):168-81. PubMed ID: 18082413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
    Arnoux D; Boutière B; Sanmarco M
    Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper Venom Time and dilute Kaolin Clotting Time detect different populations of antibodies in patients with the "antiphospholipid" syndrome.
    Kandiah DA; Krilis SA
    Thromb Haemost; 1998 Aug; 80(2):250-7. PubMed ID: 9716148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
    Bertolaccini ML; Hughes GR; Khamashta MA
    Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiphospholipid syndrome: when does the presence of antiphospholipid antibodies require therapy?
    Devine DV; Brigden ML
    Postgrad Med; 1996 Jun; 99(6):105-8, 113-25. PubMed ID: 8668625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticardiolipin and anti-beta-2-glycoprotein I antibodies.
    Marai I; Tincani A; Balestrieri G; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):33-8. PubMed ID: 15804703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of acquired resistance to activated protein C associated with antiphospholipid antibodies using a novel clotting assay.
    Gardiner C; Cohen H; Jenkins A; Machin SJ; Mackie IJ
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):477-83. PubMed ID: 16905952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome].
    Ieko M; Nakabayashi T; Tarumi T; Yoshida M; Naito S; Atsumi T; Koike T
    Rinsho Byori; 2006 Mar; 54(3):256-62. PubMed ID: 16637574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid antibody syndrome. A literature review.
    Lao M; Setty S; Foss C
    Minn Med; 2001 Apr; 84(4):42-6. PubMed ID: 11367816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thrombosis in the antiphospholipid syndrome.
    Farmer-Boatwright MK; Roubey RA
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
    Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H
    Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiphospholipid antibodies. Review].
    Diez-Ewald M
    Invest Clin; 1993; 34(3):143-58. PubMed ID: 8155777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory detection of the antiphospholipid syndrome via calibrated automated thrombography.
    Devreese K; Peerlinck K; Arnout J; Hoylaerts MF
    Thromb Haemost; 2009 Jan; 101(1):185-96. PubMed ID: 19132207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-beta2-glycoprotein I and anti-prothrombin antibodies in patients with the 'antiphospholipid' syndrome: immunological specificity and clotting profiles.
    Kandiah DA; Krilis SA
    Lupus; 1998; 7(5):323-32. PubMed ID: 9696136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome.
    Urbanus RT; Derksen RH; de Groot PG
    Blood Rev; 2008 Mar; 22(2):93-105. PubMed ID: 17964017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-beta 2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease.
    Salobir B; Sabovic M; Hojnik M; Cucnik S; Kveder T
    Immunobiology; 2007; 212(3):193-9. PubMed ID: 17412286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protean clinical presentation of antiphospholipid-protein antibodies (APA).
    Triplett DA
    Thromb Haemost; 1995 Jul; 74(1):329-37. PubMed ID: 8578480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.